Pfizer CEO Gets Pay Raise for Influencing Public Policy
Lawmakers often contend that lobbying, campaign contributions and fancy parties do not sway their votes, yet at least one company begs to differ. As The Washington Examiner reports, Pfizer based its recent decision to grant CEO Jeff Kindler a raise, at least in part, on his "developing and advancing U.S. and global public policies that serve the overall interests of our Company and our shareholders."
The language, buried in the company's most recent proxy statement filed with the Securities and Exchange Commission, … more…
Read MoreWith Travel Expenses, Some in Congress Keep the Change
Watch Politicians Debate Health Care—And Watch Their Donors
Inside the Administration’s Deal with the Pharmaceutical Lobby
Congressional Fundraising Stays Out of the Limelight at Super Bowl
Despite Reforms, Payday Lenders Continue High-Interest Loans
Identity of Americans with Secret UBS Accounts May Remain Secret
U.S. Private Security Firms Head to Haiti
More Lobbying, Less Registration: Influence-Peddling Goes Underground
Study: At Public Universities, Aid Goes to Relatively Wealthy
Help Us Keep an Eye on Stimulus Contractors
Email: .(JavaScript must be enabled to view this email address)
Sebastian Jones has written for The Nation after a recent stint as the magazine's Washington, D.C., intern. He’s previously contributed to the Web sites of Harper’s and The American Prospect and lives in Brooklyn.
© Copyright 2010 Pro Publica Inc.
FREE REPRINTS
Unless otherwise noted, you can republish our articles and graphics (but not our photographs) for free. You just have to credit us and link to us, and you can’t edit our material or sell it separately. (We're licensed under Creative Commons, which provides the legal details.)